Patent · US Active

Heterocyclic sulfonamide derivatives

US8466289B2 · kind B2 · utility

1Cited by

4References

11Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Mark G. Bock · Hatfield, US
Dinesh Chikkanna · Bengaluru, IN
Clive McCarthy · Woodstock, GB
Henrik Moebitz · Glückstadt, DE
Chetan Pandit · Edmonton, CA

Key dates

Filing date	Nov 3, 2010
Grant date	Jun 18, 2013
Priority date	—
Expiry date	Jun 5, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula Iwhere R1a, R1b, X, R2a, R2b, W, R3, R4, and R5 are as defined herein as well as pharmaceutically acceptable salts thereof. The compounds have been shown to act as MEK inhibitors which may be useful in the treatment of hyperproliferative diseases, like cancer and inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.